- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
February 1st, 2005
"We have demonstrated the first diagnostic test for the potential Alzheimer's biomarker known as an ADDL," said Chad Mirkin, director of Northwestern's Institute for Nanotechnology. "This protein is only 5 nm wide and present in cerebrospinal fluid at very low concentration, making it difficult to detect. Our bio-barcode-amplification technology, which is a million times more sensitive than any other diagnostic technology, can accurately identify ADDLs even in CSF."
The bio-barcode-amplification technique uses 30 nm-diameter gold nanoparticles and magnetic microparticles.
|Related News Press|
Simulations predict flat liquid May 21st, 2015
Researchers develop new way to manufacture nanofibers May 21st, 2015
Effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015
Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015